Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation

Authors

  • Virginie Lambrecq MD,

    Corresponding author
    1. Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université Bordeaux 2, Bordeaux, France
    • Service de Neurophysiologie Clinique, Centre Hospitalier Universitaire Pellegrin, Bordeaux, France
    Search for more papers by this author
  • Florence Riant MD, PhD,

    1. Laboratoire Histologie Embryologie Cytogénétique, Hôpital Lariboisière, Paris, France
    Search for more papers by this author
  • Elisabeth Tournier-Lasserve MD, PhD,

    1. Laboratoire Histologie Embryologie Cytogénétique, Hôpital Lariboisière, Paris, France
    Search for more papers by this author
  • Véronique Michel MD,

    1. Service de Neurophysiologie Clinique, Centre Hospitalier Universitaire Pellegrin, Bordeaux, France
    2. Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université Bordeaux 2, Bordeaux, France
    Search for more papers by this author
  • Pierre Burbaud MD, PhD

    1. Service de Neurophysiologie Clinique, Centre Hospitalier Universitaire Pellegrin, Bordeaux, France
    2. Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université Bordeaux 2, Bordeaux, France
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

Correspondence to: Dr. Virginie Lambrecq, Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France; vlambrecq@hotmail.fr

No abstract is available for this article.

Ancillary